Application:
The Electrical Mapping Systems (EMS) are equipped with the new generation of Multi-Electrode Arays(MEAs) and high-perfomance amplifiers. The advanced EMapping software facilitates fast recordings offield potentials from in vitro, in vivo, and ex vivo cardiac samples. The electrical activities and conductiveinformation can be studied in great detail at the tissue level. The precision of data acquisition systemmakes it possible to accurately detect abnormalities on ion channels. lt also can be grouped with otherdevices such as ventricular or coronary pressure probes, monophasic action potential system (MAP)myocardial tension, perfusion temperature, and the optical mapping system. These features immenselyempower cardiac electrophysiological researchers to understand better about mechanisms of cardiacarrhythmias. Our system is also an ideal candid ate for efficiently screening new anti-arrhythmic drugs andtesting drug toxicity.

Applicable animals:
Zebrafish, mice, rats, guinea pigs, rabbits, dogs, sheep, pigs, monkeys.

Applicable tissues:
cardiac slices and tissues, conductive tissues including sinoatrial node.atrioventricular node, Purkinje fibers, iPsC cells as well as in vivo and ex vivo heart, may also applicableto Retina, brain slices gastrointestinal tissues and uterus with customized system.

Features:
·High-performance amplifiers and analog-digital converters (ADCs).
·Advanced acquisition and intuitive analysis software.
·Datatransmission: USB or PXl fibre optic transmission.
·Various size and layout.
·Up to 16 additional channels.
·Multiple input/output (l/0) connectors.
·USB CCD camera.
·12VDC power supply.

 

MappingLab is a leading enterprise specializing in the R&D of electrophysiological mapping scientific research equipment, co-founded by world-renowned, highly experienced scientists from the University of Oxford and the University of Manchester in the United Kingdom. PEVI Instruments Co. Ltd, Henan serves as MappingLab's translational entity in China, holding the registered trademark of MappingLab for the Chinese market. In late 2023, the company successfully established a localized production line for MappingLab in China.

Our mission is to provide the global community of electrophysiological researchers with the highest-quality mapping systems, and to address the critical challenges in electrophysiological detection across key areas including the fundamental research on the mechanisms of heart diseases, preclinical cardiac safety evaluation of pharmaceuticals, and the electrophysiological testing of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and other differentiated cells.

To date, leveraging our robust product advantages, comprehensive professional technical support, extensive practical experience, and a commitment to rigorous customer service, our core products—including Electrical Mapping systems and Optical mapping systems—have been widely adopted by research institutions worldwide. We have forged strategic collaborations with the most esteemed experts in the global electrophysiological research field and established a strong network of authorized equipment distributors.

Additionally, we maintain close academic exchanges with a roster of world-class universities and research institutions, such as the University of Oxford, the University of Manchester, Harvard University, Peking University, the University of Toronto, and the University of Technology Sydney.

At MappingLab, we are unwaveringly dedicated to designing and developing highly automated instruments for researchers across the globe. We uphold a customer-centric approach by empowering .